Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05496036
Title Neoadjuvant PD-1 Blockade in Resectable Merkel Cell Carcinoma (MCC)
Acronym MCC
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Abramson Cancer Center of the University of Pennsylvania
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.